Roberto Borea, Postdoctoral Research at Ohio State University Comprehensive Cancer Center-James Cancer Hospital and Solove Research Institute, shared a post on LinkedIn:
“Liquid Biopsy in Stage III NSCLC?
New Real-World data in ESMO Open from Umberto Malapelle
– 93% Concordance with tissue
– 8 days vs 32 for tissue
– 98% Specificity
A crucial complementary tool to accelerate EGFR detection in lung cancer.”
More posts featuring Roberto Borea on OncoDaily.